Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to find optimum dosage of DW-3101 by evaluating efficacy and safety of each dosage group in Korean patients with acute and chronic gastric inflammation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DW-3101_150mg | Experimental | 150mg a day |
|
| DW-3101_300mg | Experimental | 300mg a day |
|
| DW-3101_600mg | Experimental | 600mg a day |
|
| a tablet same as experimental agents in formation and shape | Placebo Comparator | Placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DW-3101_150mg | Drug |
| ||
| DW-3101_300mg |
| Measure | Description | Time Frame |
|---|---|---|
| The change of gastric erosion score | The erosion score is evaluated by gastroscopy. Erosion score The number of erosion
| 14day±3 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| DW-3101_600mg | Drug |
|
| Placebo | Drug |
|